Kineticos Disruptor Fund and Eos Advisory Form Partnership To Invest In Disruptive Life Science Companies in Scotland

Kineticos Announces Promotion of Philip Gialenios to President and COO

Kineticos’ Founder and CEO, Shailesh Maingi Joins Arranta Bio Board as Independent Director

Kineticos Disruptor Fund Leads Promaxo’s Series B-1 Funding Round

Kineticos Announces New Life Sciences Disruptor Fund That Will Launch and Invest in Early Stage Biotechs

Kineticos Welcomes New Senior Team Member – Dan McCormick

Meet Kevin Hampton, SVP of Kineticos’ Early Stage Biopharma Practice

Meet Abe Maingi, Kineticos’ New VP of Precision Medicine

Kineticos Prepares for Next Phase of Growth Expanding Its Senior Team

Kineticos Wins Triangle Business Journal’s 2019 Life Sciences Consultant of the Year

Kineticos to Attend BIO 2017

Kineticos to Sponsor February 27th Life Science Forum

Kineticos to Sponsor the Q4 Life Science Forum

Kineticos Expands Biopharmaceutical Practice Leadership Team, Bolsters Oncology Focus with Senior Vice President Appointment

Kineticos to Sponsor Life Science Forum

Kineticos and Cardinal Health Regulatory Sciences to host a live webinar – “Achieving Success in the Biosimilars Market”

Kineticos Featured in Ivy Exec’s Company Spotlight Series

Kineticos to Sponsor the Q2 Life Sciences Forum on May 23rd at the NC Biotech Center

Confidence Wanes as Uncertainty Builds in the Q4 2015 Biopharma CEO Confidence Index

Kineticos to Sponsor Life Sciences Forum on February 29th at the NC Biotech Center

Kineticos Expands Biopharmaceutical Practice Leadership Team with Two Senior Executive Appointments

Kineticos Adopts Practice Area Structure, Expands Consulting Service Areas

James Forte Joins Kineticos as Managing Director

Christopher Church Joins Kineticos as Managing Director

LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment